Acadia Pharmaceuticals Inc (ACAD)
$20.59 -0.82% Close Oct 30, 2026 Live
Acadia Pharmaceuticals stock today
Acadia Pharmaceuticals closed at $20.59 on October 30, 2026, down 0.82% on the day. Over the past year it returned -9.5% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $3.53 billion.
$20.00$25.00$30.00
NovJan 2026MarMayJulSep
| Period | ACAD | S&P 500 (SPY) |
|---|---|---|
| 1 month | +2.2% | -0.9% |
| 3 months | -22.4% | +2.1% |
| Year to date | -22.9% | +11.7% |
| 1 year | -9.5% | +12.4% |
| 3 years | -7.4% | +88.5% |
| 5 years | +14.7% | +76.0% |
Key statistics
- Market value
- $3.53B
- P/E (trailing)
- 9.2
- Forward P/E
- 27.2
- Price / sales
- 3.1
- 52-week range
- $18.62 to $30.57
- Next report
- Nov 4, 2026
About Acadia Pharmaceuticals
Develops and commercializes psychiatric and neurological pharmaceutical products.
Sector: Health Care
More on Acadia Pharmaceuticals
- Financials: revenue, earnings and segmentsRevenue +12% in the year to Dec 2025
- Valuation: P/E history and peersP/E 9.2
- Returns: what $1,000 became$1,000 ten years ago is $912.27 today
No forecast, no recommendation. This page describes Acadia Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.